Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2020 Earnings Conference Call December 9, 2019 4:30 PM ET Company Participants Rick Hancock - Interim President and CEO Dan Hart - CFO Tracy Kinjerski - VP of Business Operations Tim Brons - IR Conference Call Participants Joseph Pantginis - H.C. Wainwright Matt Hewitt - Craig-Hallum Capital Jacob Johnson - Stephens Inc. Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices Second Quarter 2020 Financial Results Conference Call. At this time, all ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC 10.50% Series E Convertible Preferred Stock, $0.001 par value per share CDMOP The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 or o TRANSITIO ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q1 2020 Earnings Conference Call September 5, 2019 4:30 PM ET Company Participants Tim Brons - IR Rick Hancock - Interim President & CEO Dan Hart - CFO Tracy Kinjerski - VP of Business Operations Conference Call Participants Paul Knight - Janney Montgomery Steve Schwartz - First Analyst Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices First Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to hand the con ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ | --- | |---------------------------------------------------------------------------------------------------| | | | | | Commission file n ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q4 2019 Results Conference Call June 27, 2019 4:30 PM ET Company Participants Tim Brons - Investor Relations Rick Hancock - Interim President and CEO Dan Hart - Chief Financial Officer Tracy Kinjerski - Vice President of Business Operations Conference Call Participants Joe Pantginis - H.C. Wainwright Paul Knight - Janney Montgomery Steve Schwartz - First Analyst Operator Good day, ladies and gentlemen. And welcome to the Avid Bioservices' Fourth Quarter and Year-End 2019 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-32839 AVID BIOSERVICES, INC. (Exact name of Registrant as specified in its charter) Delaware ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2019 Results Earnings Conference Call March 11, 2019 4:30 PM ET Company Participants Tim Brons - Investor Relations Roger Lias - President and Chief Executive Officer Daniel Hart - Chief Financial Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Paul Knight - Janney Montgomery Steven Schwartz - First Analyst Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices’ Third Quarter 2019 Financial Results Conference Call. At this ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-32839 AVID BIOSERVICES, INC. (Exact name of Registrant as specified in its charter) De ...